Cerus Corp Files Q2 2024 10-Q

Ticker: CERS · Form: 10-Q · Filed: Aug 1, 2024 · CIK: 1020214

Cerus Corp 10-Q Filing Summary
FieldDetail
CompanyCerus Corp (CERS)
Form Type10-Q
Filed DateAug 1, 2024
Risk Levelmedium
Pages15
Reading Time18 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, reporting

TL;DR

**Cerus Corp Q2 10-Q filed. Financials and operations update.**

AI Summary

Cerus Corp filed its 10-Q for the period ending June 30, 2024. The filing details the company's financial performance and operational status. Key financial data and business updates are provided for investors and stakeholders.

Why It Matters

This filing provides crucial financial and operational insights into Cerus Corp's performance during the second quarter of 2024, impacting investor decisions and market perception.

Risk Assessment

Risk Level: medium — 10-Q filings are standard for public companies, but the specific financial details and operational risks disclosed within can significantly impact a company's stock price.

Key Numbers

  • 1231 — Fiscal Year End (Indicates the end of the company's annual financial reporting cycle.)

Key Players & Entities

  • CERUS CORP (company) — Filer of the 10-Q
  • 20240630 (date) — End of the reporting period
  • 20240801 (date) — Filing date
  • DE (location) — State of incorporation
  • CONCORD (location) — Business and mailing address city

FAQ

What is the reporting period for this 10-Q filing?

The Conformed Period of Report is 20240630, meaning the filing covers the period ending June 30, 2024.

When was this 10-Q filed with the SEC?

The filing date (FILED AS OF DATE) is 20240801.

What is Cerus Corp's Standard Industrial Classification (SIC) code?

Cerus Corp's SIC code is 3841, which corresponds to 'Surgical & Medical Instruments & Apparatus'.

In which state is Cerus Corp incorporated?

Cerus Corp is incorporated in Delaware (DE).

What is the business address of Cerus Corp?

The business address is 1220 Concord Avenue, Suite 600, Concord, CA 94520.

Filing Stats: 4,377 words · 18 min read · ~15 pages · Grade level 17.3 · Accepted 2024-08-01 16:54:45

Key Financial Figures

  • $0.001 — h Registered Common Stock , par value $0.001 per share CERS The Nasdaq Stock Mar

Filing Documents

Financial Statements

Financial Statements 1 Condensed Consolidated Balance Sheets – June 30, 2024 and December 31, 2023 1 Condensed Consolidated Statements of Operations – Three and six months ended June 30, 2024 and 2023 2 Condensed Consolidated Statements of Comprehensive Loss – Three and six months ended June 30, 2024 and 2023 3 Condensed Consolidated Statements of Stockholders' Equity – Three and six months ended June 30, 2024 and 2023 4 Condensed Consolidated Statements of Cash Flows – Six months ended June 30, 2024 and 2023 5 Notes to Condensed Consolidated Financial Statements 6 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 22 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 32 Item 4.

Controls and Procedures

Controls and Procedures 32 PART II OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 34 Item 1A.

Risk Factors

Risk Factors 34 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 72 Item 3. Defaults Upon Senior Securities 72 Item 4. Mine Safety Disclosures 72 Item 5. Other Information 72 Item 6. Exhibits 73

: FINANCI AL INFORMATION

PART I: FINANCI AL INFORMATION

FINANC IAL STATEMENTS

ITEM 1. FINANC IAL STATEMENTS CERUS CORPORATION CONDENSED CONSOLIDA TED BALANCE SHEETS (in thousands) June 30, December 31, 2024 2023 (Unaudited) ASSETS Current assets: Cash and cash equivalents $ 12,402 $ 11,647 Short-term investments 58,792 54,205 Accounts receivable, net 23,740 35,500 Current inventories 36,290 39,868 Prepaid and other current assets 3,806 3,221 Total current assets 135,030 144,441 Non-current assets: Property and equipment, net 7,781 8,640 Operating lease right-of-use assets 9,581 10,713 Goodwill 1,316 1,316 Restricted cash 1,708 1,712 Non-current inventories 16,801 19,501 Other assets 13,279 11,425 Total assets $ 185,496 $ 197,748 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 16,739 $ 23,842 Accrued liabilities 15,048 19,225 Debt – current 18,782 20,000 Operating lease liabilities – current 2,219 2,452 Deferred revenue 1,096 2,002 Total current liabilities 53,884 67,521 Non-current liabilities: Debt – non-current 64,840 59,796 Operating lease liabilities – non-current 12,851 13,751 Other non-current liabilities 3,620 3,236 Total liabilities 135,195 144,304 Commitments and contingencies Stockholders' equity: Common stock 185 181 Additional paid-in capital 1,110,264 1,098,353 Accumulated other comprehensive loss ( 867 ) ( 1,274 ) Accumulated deficit ( 1,060,073 ) ( 1,044,610 ) Total Cerus Corporation stockholders' equity 49,509 52,650 Noncontrolling interest 792 794 Total liabilities and stockholders' equity $ 185,496 $ 197,748 See accompanying Notes to Condensed Consolidated Financial Statements. 1 CERUS CORPORATION CONDENSED CONSOLIDATED S TATEMENTS OF OPERATIONS UNAUDITED (in thousands, except per share data) Three Months Ended Six Months Ended June 30, June 30,

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.